Acute Myelocytic Leukemia with Polyposis Coli and Colon Cancer
acute myeloid leukemia with BCR-ABL1
acute myeloid leukemia with biallelic mutation of CEBPA
acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)
acute myeloid leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2)
acute myeloid leukemia with maturation
acute myeloid leukemia with minimal differentiation
acute myeloid leukemia with MLL rearrangement
acute myeloid leukemia with mutated CEBPA
acute myeloid leukemia with mutated NPM1
acute myeloid leukemia with mutated RUNX1
acute myeloid leukemia with myelodysplasia-related changes
acute myeloid leukemia with t(1;22)(p13;q13)
acute myeloid leukemia with t(6;9) (p23;q34.1)
acute myeloid leukemia with t(8;21); (q22; q22.1)
acute myeloid leukemia without maturation
acute myelomonocytic leukemia
acute promyelocytic leukemia +
childhood acute myeloid leukemia
core binding factor acute myeloid leukemia
An acute myeloid leukemia that is characterized by the presence of t(8;21)(q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22). These cytogenetic abnormalities result in disruption of the transcription factor CBF, which is a regulator of normal hematopoiesis. (DO)
Dohle Bodies and Leukemia
Familial Acute Myeloid Leukemia with Mutated Cebpa
Familial Erythroleukemia
Familial Platelet Disorder with Associated Myeloid Malignancy